Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 47801-47850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06561529
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
NARecruiting
10 participants
Started: Jun 13, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT06322108
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
PHASE2Recruiting
45 participants
Started: Jun 13, 2024 · Completed: Apr 30, 2030
1 condition2 sponsors1 location
NCT06458725
Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers
NANot yet recruiting
30 participants
Started: Jun 13, 2024 · Completed: Nov 30, 2024
2 conditions1 sponsor0 locations
NCT06186570
Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders
NARecruiting
86 participants
Started: Jun 13, 2024 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT06455826
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
PHASE1Recruiting
12 participants
Started: Jun 13, 2024 · Completed: Nov 30, 2025
5 conditions1 sponsor5 locations
NCT06645262
First-degree Ankle Sprains
N/ARecruiting
100 participants
Started: Jun 12, 2024 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06425627
Spinal Versus General Anesthesia on Postoperative Pulmonary Complications
NARecruiting
40 participants
Started: Jun 12, 2024 · Completed: May 20, 2026
3 conditions1 sponsor1 location
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
115 participants
Started: Jun 12, 2024 · Completed: Feb 28, 2029
16 conditions1 sponsor6 locations
NCT06396286
Spine Surgery for Lenke 1 Adolescent Idiopathic Scoliosis
NARecruiting
20 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06303505
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
PHASE1/PHASE2Recruiting
100 participants
Started: Jun 12, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor12 locations
NCT06332313
Erector Spina Plane Block Volume Comparison
NANot yet recruiting
60 participants
Started: Jun 12, 2024 · Completed: Dec 5, 2024
1 condition1 sponsor0 locations
NCT06294028
International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease with Minimally Impaired Ejection Fraction
NARecruiting
268 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT06843928
The Adjunctive Effect of a Titanium Brush in the Non-Surgical Treatment of Peri-Implantitis
NARecruiting
36 participants
Started: Jun 12, 2024 · Completed: Jul 16, 2026
3 conditions1 sponsor1 location
NCT06438913
Tezepelumab Treatment in Korean Severe Asthma Patients
N/ANot yet recruiting
100 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06208189
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
NAActive, not recruiting
15 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06409702
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
PHASE4Recruiting
59 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT06581744
Non Invasive Imaging Methods for Detecting PA:a Clinical PET Study of 18F-Pentixather
NARecruiting
20 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06461000
EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
N/ARecruiting
1,000 participants
Started: Jun 12, 2024 · Completed: Jun 12, 2029
2 conditions1 sponsor1 location
NCT06375564
Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression
PHASE1Recruiting
20 participants
Started: Jun 12, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06480240
A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor8 locations
NCT06382168
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
39 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT06408181
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
PHASE3Recruiting
1,150 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2029
2 conditions2 sponsors1 location
NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
EARLY_PHASE1Recruiting
24 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06831812
Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine
PHASE1Active, not recruiting
16 participants
Started: Jun 12, 2024 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT06414135
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
PHASE1Recruiting
6 participants
Started: Jun 12, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT06624241
Effectiveness of SRP+ Lipo-curcumin Gel for the Treatment of Stage III Periodontitis.
NARecruiting
40 participants
Started: Jun 12, 2024 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT06405347
The M-Well Inpatient Whole Health Bundle
NARecruiting
900 participants
Started: Jun 12, 2024 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06682455
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)
N/AEnrolling by invitation
300 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2027
1 condition7 sponsors8 locations
NCT06136728
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
PHASE4Recruiting
48 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06078267
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure (Beta Study)
NANot yet recruiting
75 participants
Started: Jun 12, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT04546685
"Virtual 1-Session Spanish Empowered Relief Group Intervention for Chronic Pain"
NARecruiting
110 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT07034105
Spatiotemporal Gait Parameters of Healthy and Stroke Patients During Overground, Treadmill, and Body Weight Supported Treadmill Walking
NARecruiting
25 participants
Started: Jun 12, 2024 · Completed: Feb 11, 2026
1 condition2 sponsors1 location
NCT05422690
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
PHASE2Recruiting
16 participants
Started: Jun 12, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT06813365
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
PHASE1Recruiting
76 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06439589
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
88 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06427629
Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device
NARecruiting
148 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06456125
Safety and Efficacy Of Amber Peripheral Liquid Embolic System
NAActive, not recruiting
70 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2026
9 conditions1 sponsor1 location
NCT06435351
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
EARLY_PHASE1Recruiting
16 participants
Started: Jun 12, 2024 · Completed: May 31, 2029
2 conditions1 sponsor1 location
NCT06788821
Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology
N/ARecruiting
440 participants
Started: Jun 12, 2024 · Completed: Mar 1, 2026
1 condition1 sponsor2 locations
NCT06737991
Effects of Chest Expansion Exercises on Thoracic Expansion and VO2 Max in Children With Chest Burn
NAActive, not recruiting
33 participants
Started: Jun 12, 2024 · Completed: Dec 17, 2024
1 condition1 sponsor1 location
NCT06769893
A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging
NARecruiting
60 participants
Started: Jun 12, 2024 · Completed: Nov 7, 2025
1 condition1 sponsor1 location
NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
PHASE2Recruiting
252 participants
Started: Jun 12, 2024 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT06673407
Group Exposure Workshops for Socially Anxious Undergraduates
NARecruiting
200 participants
Started: Jun 12, 2024 · Completed: Oct 1, 2025
4 conditions1 sponsor1 location
NCT06389136
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
PHASE3Recruiting
200 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor96 locations
NCT06255392
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
PHASE3Recruiting
200 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2031
2 conditions1 sponsor1 location
NCT06389513
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
PHASE4Active, not recruiting
3,011 participants
Started: Jun 12, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06373328
Post Pandemic Pneumococcal Carriage Among Children and Adults
N/ARecruiting
900 participants
Started: Jun 12, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06405516
Platelet Function After Cardiac Surgery.
NARecruiting
40 participants
Started: Jun 12, 2024 · Completed: Jan 1, 2026
1 condition3 sponsors1 location
NCT06465342
LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)
N/ANot yet recruiting
80 participants
Started: Jun 12, 2024 · Completed: Dec 12, 2025
1 condition1 sponsor0 locations
NCT06173154
Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID)
NARecruiting
76 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location